Back

HFpEF as a cardiometabolic syndrome.

29 August 2021 (12:11 - 12:22)
Organised by:
Congress Presentation Part of: HFpEF: different mechanistic phenotypes require distinct therapeutic strategies Basic Science ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Professor Nazha Hamdani

Ruhr University Bochum, Bochum (Germany)

3 More presentations in this session

Presentation thumbnail
HFpEF as a coronary inflammatory syndrome.
Professor S. Heymans (Maastricht, NL)
Slides
Presentation thumbnail
HFpEF as a cardiorenal syndrome.
Professor J. Fang (Salt Lake City, US)
Slides
Presentation thumbnail
HFpEF: different mechanistic phenotypes require distinct therapeutic strategies – discussion.

Access the full session

Session thumbnail
HFpEF: different mechanistic phenotypes require distinct therapeutic strategies
Video

The Event

Event poster

ESC Congress 2021 - The Digital Experience

29 August 2021 12:11 CET
You may be interested in
thumbnail
Webinar
GLP-1 RAs and HFpEF: which HFpEF patients should now be receiving GLP-1 RAs?
15 December 2025
thumbnail
Congress Session
Redefining mineralocorticoid receptor antagonism in cardio-kidney-metabolic syndrome: from evidence to innovation
18 May 2025
thumbnail
Congress Presentation
Metabolic syndrome contributes to the pulmonary arterial dysfunction in pulmonary hypertension in heart failure with preserved ejection fraction
31 August 2020
thumbnail
Congress Presentation
Cardiometabolic differences between patients with reduced and preserved ejection fraction: a proposal for phenotyping
22 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources